Trial Profile
A Randomised, Double-blind, Double-dummy, Parallel-group Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-malignant Pain Taking Oxycodone Equivalent of 60-80 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged Release Tablets Alone
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary) ; Oxycodone
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Mundipharma GmbH
- 02 Sep 2010 Results presented at the 13th World Congress on Pain.
- 28 Jul 2009 Planned end date changed from Feb 2008 to Jul 2008 as reported by ClinicalTrials.gov.
- 16 Oct 2008 Status changed from active, no longer recruiting to completed.